国产孟鲁司特钠早期应用对患儿急性呼吸道感染后咳嗽的影响

Effect of early application of domestic montelukast on treatment of acute respiratory tract infection children complicated with cough

  • 摘要: 目的 探讨既往有呼吸道感染后咳嗽病史的患儿,急性呼吸道感染后早期应用国产孟鲁司特钠,对呼吸道感染后咳嗽的影响。方法 选择既往有呼吸道感染后咳嗽病史的急性呼吸道感染患者,随机分治疗组和对照组。治疗组145例,对照组141例。发热时间均在24小时之内就诊。两组性别、年龄、就诊发热时间经统计学处理具有可比性。治疗组加用国产孟鲁司特钠5 mg,每天一次21天,其他治疗方案不变。两组经过治疗后观察患儿咳嗽发生的时间、程度、持续时间(从发病第1、3、5、7天)、>4周(28天后)给予评分。咳嗽程度按评分多少比较;并进行药物不良反应监测。结果 治疗组与对照组比较:评分在第1天咳嗽无差异,第3、5、7天、>4周咳嗽有差异(P<0.01)。治疗组在第3、5、7天、>4周发生咳嗽分别为51例、70例、88例、11例。对照组在第3、5、7天、>4周发生咳嗽分别为99例、110例、128例、28例。两组对比均有差异(P<0.01)。在治疗组观察与孟鲁司特钠相关药物不良反应5例,表现为头痛,兴奋、睡眠不安,一周后消失。结论 既往有呼吸道感染后咳嗽病史的患儿,在急性呼吸道感染后早期应用国产孟鲁司特钠,能够有效减轻或减少呼吸道感染咳嗽的发生,特别是慢性咳嗽发生。

     

    Abstract: OBJECTIVE To explore the effect of domestic montelukast on treatment of acute respiratory tract infection children complicated with cough. METHODS The patients with acute respiratory tract infection who had history of cough were enrolled in the study and randomly divided into the treatment group and the contnol group, with 145 cases in the treatment group, 141 cases in the control group. The two groups of patients were treated within 24 hours of fever. The gender, age and fever time at the treatment were statistically comparable between the two groups of patients. The treatment group was given additional 5mg of domestic montelukast for 21 days, once a day, and other treatment plans were as same as those of the control group. The time, severity and duration (from the onset to the 1st,3rd,5th and 7th day)of cough as well as the duration of cough for more than 4 weeks (28 days) were observed and scored after the treatment, the severity of cough was compared based on the scores; the drug-induced adverse reactions were monitored. RESULTS There was no significant difference in the score of cough on the 1st day between the two groups of patients; there were significant differences in the scores of cough on the 3rd, 5th and 7th day as well as for more than 4 weeks (P<0.01). In the treatment group, there were 51 cases of cough on the 3rd day, 70 cases on the 5th day, 88 cases on the 7th day, 11 cases for more than 4 weeks. In the control group, there were 99 cases of cough on the 3rd day, 110 cases on the 5th day, 128 cases on the 7th day, 28 cases for more than 4 weeks; there were significant differences between the two groups (P<0.01). Totally 5 patients had montelukast-induced adverse reactions in the treatment group, manifesting as headache, excitement and restlessness of sleep, which disappeared after 1 week. CONCLUSION The early application of domestic montelukast may effectively alleviate or reduce the incidence of cough, especially the chronic cough,in the children who have acute respiratory tract infection.

     

/

返回文章
返回